Lauren Brown advises public companies regarding compliance with federal and state securities laws, reporting and disclosure obligations (including regularly reviewing and preparing Forms 10-K, 10-Q and 8-K and proxy statements), compliance with stock exchange rules (including the NYSE and the Nasdaq Stock Market) and Section 16 reporting obligations. She works closely with in-house counsel, company leadership, and boards of directors to address shareholder activism, compliance issues, reporting obligations, and regulatory requirements.
Prior to joining Bass, Berry & Sims, Lauren was an associate in the corporate group at Vorys, Sater, Seymour and Pease LLP in Columbus, Ohio, where she represented public and private companies on strategic transactions and compliance matters. Lauren earned her law degree from Washington and Lee University School of Law and a B.A. in political science and communication from Denison University.
American Health Law Association (AHLA)
Children’s Hunger Alliance — Central Ohio Regional Advisory Board (2019-2021)
Women for Economic and Leadership Development — National Advisory Council, Co-Chair (2019-Present)
Representation of LFM Capital, a private equity firm focused on lower middle market manufacturing and industrial services businesses, in its sale of Fecon, LLC., a leading manufacturer of heavy-duty forestry mulching equipment and related accessories in North America, to WindJammer Capital investors. Terms of the transaction were not disclosed.
Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management. Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.
Washington and Lee Law Review